PDCD1 and neoplasm: A humanized monoclonal antibody that acts as a programmed cell death ligand (PD-L1) blockade agent that binds to PD-L1 on tumor cells and blocks its interaction with T-cells and antigen presenting cell PD-1, thereby relieving PD-1/PD-L1-mediated immune suppression and promoting T-cells to attack tumor cells